Team Hyi-Man Park, Ph.D.

Dr. Hyi-Man Park oversees research and development initiatives at PRISM BioLab as Head of the Research and Development Department. He leads the company’s R&D strategy and execution across multiple programs. Prior to joining PRISM BioLab, he served as Head of Biology at RaQualia Pharma Inc., a spin-off from Pfizer Research Center Japan. Before that, he worked at the Novartis Institutes for BioMedical Research (NIBR) in Cambridge, where he initiated and led novel drug discovery projects in the cardiovascular and oncology areas. He led multiple projects from target identification through the preclinical stage. He serves as an Industry Advisor to the SPARK Translational Medicine Program at Stanford University and previously held a position as a Designated Professor at Nagoya University. He received both his undergraduate and Ph.D. degrees from Nagoya University and completed his post-doc at the University of Minnesota.